Kymera Therapeutics, Inc. (KYMR) › Shareholders' EquityKymera Therapeutics, Inc. (KYMR) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$34.44M2019: -$74.41M2020: $283.89M2021: $459.64M2022: $490.15M2023: $394.97M2024: $835.62M2025: $1.58B$1.58B2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$1.58B+89.0%2024$835.62M+111.6%2023$394.97M-19.4%2022$490.15M+6.6%2021$459.64M+61.9%2020$283.89M+481.5%2019-$74.41M-116.1%2018-$34.44M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share